《大行報告》瑞銀首予呷哺呷哺(00520.HK)「買入」評級 目標價11元
瑞銀髮表研究報告,首次給予呷哺呷哺(00520.HK)「買入」評級,指出該公司的股價自2月11日起已累計下跌72%,主要由於市場關注管理層變動,認爲投資者屬過分憂慮。
該行指出,管理層變動對經營層面的影響可控,今年公司旗下高端品牌「湊湊火鍋」擬按計劃在今年淨增70家分店,估計分店數量至2023年將大幅增加至480家,未來三年的擴充可帶動盈利持續增長,預期2021至2023年每股盈利複合增長約33%。
瑞銀基於2022年預測市盈率約17倍,給予呷哺呷哺目標價11元,考慮到湊湊火鍋的店鋪擴充計劃,認爲現價水平爲2022年預測市盈率約11倍,爲同業中最低,估值吸引。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.